About Biomarx
Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting with lung cancer.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Pre-Seed
Global Headquarters
Undisclosed
Tracked Since
Nov 6, 2026
Web & Domain Identity
Official Website
biomarx.co.uk
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $940,000 · Pre-Seed
startupintros.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Biomarx.
Funding History
Pre-Seed equity
· Jan 5, 2026
$940,000 startupintros.com
Founders & Leadership
Sean Macfarlane
Founder & CEO
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026